Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance

Molecular Microbiology
G ManinaGiovanna Riccardi

Abstract

Tuberculosis is still a leading cause of death in developing countries, for which there is an urgent need for new pharmacological agents. The synthesis of the novel antimycobacterial drug class of benzothiazinones (BTZs) and the identification of their cellular target as DprE1 (Rv3790), a component of the decaprenylphosphoryl-β-d-ribose 2'-epimerase complex, have been reported recently. Here, we describe the identification and characterization of a novel resistance mechanism to BTZ in Mycobacterium smegmatis. The overexpression of the nitroreductase NfnB leads to the inactivation of the drug by reduction of a critical nitro-group to an amino-group. The direct involvement of NfnB in the inactivation of the lead compound BTZ043 was demonstrated by enzymology, microbiological assays and gene knockout experiments. We also report the crystal structure of NfnB in complex with the essential cofactor flavin mononucleotide, and show that a common amino acid stretch between NfnB and DprE1 is likely to be essential for the interaction with BTZ. We performed docking analysis of NfnB-BTZ in order to understand their interaction and the mechanism of nitroreduction. Although Mycobacterium tuberculosis seems to lack nitroreductases able to ina...Continue Reading

References

Apr 15, 1997·Archives of Biochemistry and Biophysics·J Marcinkeviciene, J S Blanchard
Jan 24, 2002·The Journal of Biological Chemistry·Chad A HaynesDavid W Rodgers
Mar 27, 2003·Molecular Microbiology·Christopher M SassettiEric J Rubin
Jun 25, 2004·Nucleic Acids Research·Todd J DolinskyNathan A Baker
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·E BlancG Bricogne
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·E Krissinel, K Henrick
Sep 10, 2005·Journal of Biotechnology·Susanne van den BergHelena Berglund
Jan 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ujjini H ManjunathaClifton E Barry
Mar 23, 2006·Acta Crystallographica. Section D, Biological Crystallography·Jay Painter, Ethan A Merritt
Apr 25, 2007·Nucleic Acids Research·Ian W DavisDavid C Richardson
Aug 28, 2007·Lancet·Gary Maartens, Robert J Wilkinson
Oct 5, 2007·Expert Review of Anti-infective Therapy·Alberto MatteelliMario Raviglion
Dec 25, 2007·Acta Crystallographica. Section A, Foundations of Crystallography·George M Sheldrick
Mar 22, 2008·FEMS Microbiology Reviews·María Dolores RoldánConrado Moreno-Vivián
Jul 10, 2008·Environmental and Molecular Mutagenesis·Guosheng ChenPaul A White
Sep 27, 2008·Bioinformatics·L HolmA Schenkel
May 19, 2009·Biochemical Pharmacology·Shiuan-Woei LinwuFu-Chuo Peng
Jun 6, 2009·Future Microbiology·Giovanna RiccardiSilvia Buroni
Jan 21, 2010·Antimicrobial Agents and Chemotherapy·Maria Rosalia PascaGiovanna Riccardi
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart

❮ Previous
Next ❯

Citations

Sep 17, 2013·Applied Microbiology and Biotechnology·Giovanna RiccardiClaudia Binda
Feb 14, 2013·Journal of the American Chemical Society·Rohit TiwariMarvin J Miller
Jun 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sarah M BattGurdyal S Besra
May 12, 2011·The Journal of Antimicrobial Chemotherapy·Pedro Eduardo Almeida Almeida Da Silva, Juan Carlos Palomino
Nov 22, 2011·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Aisyah M RehanChristopher J Squire
May 24, 2011·Journal of Bacteriology·Anna GerasimovaMikhail S Gelfand
Nov 10, 2011·PloS One·Ana Luisa de Jesus Lopes RibeiroMaria Rosalia Pasca
Apr 25, 2012·Applied Microbiology and Biotechnology·Silvia BuroniGiovanna Riccardi
Sep 1, 2014·European Journal of Medicinal Chemistry·Giovanna PoceMariangela Biava
Aug 6, 2013·Nature Chemical Biology·Matteo T DegiacomiMatteo Dal Peraro
Feb 7, 2014·EMBO Molecular Medicine·Vadim MakarovStewart T Cole
Sep 21, 2012·Expert Opinion on Investigational Drugs·Jean Engohang-Ndong
Mar 17, 2012·European Journal of Medicinal Chemistry·Baptiste VillemagneNicolas Willand
Dec 7, 2010·Trends in Microbiology·Sean EkinsCarolyn Talcott
Apr 14, 2015·Protein Science : a Publication of the Protein Society·Hyung-Nam SongEui-Jeon Woo
Sep 22, 2016·Drug Discovery Today·Giorgia MoriMaria Rosalia Pasca
Jan 25, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anne-Frances MillerAndreas S Bommarius
Oct 29, 2017·Proceedings of the National Academy of Sciences of the United States of America·Eyal AkivaPatricia C Babbitt
Jul 1, 2011·Chemistry, an Asian Journal·Carolina EstarellasPere M Deyà
Sep 18, 2016·Applied and Environmental Microbiology·Thanavit JirapanjawatChris Greening
Apr 8, 2014·The Journal of Biological Chemistry·Warintra PitsawongAnne-Frances Miller
Jan 1, 2014·Antibiotics·Juan Carlos Palomino, Anandi Martin
May 11, 2017·Frontiers in Microbiology·Mohammad J NasiriMohammad M Feizabadi
Jun 25, 2018·Chemistry Central Journal·Jineetkumar Gawad, Chandrakant Bonde
Jul 19, 2018·Frontiers in Microbiology·Diana MachadoMarco Pieroni
May 15, 2018·Frontiers in Cellular and Infection Microbiology·H M Adnan HameedTianyu Zhang
Oct 8, 2020·Journal, Genetic Engineering & Biotechnology·Siarhei A Dabravolski
Nov 18, 2020·Environmental Microbiology·Huawen HanXiangkai Li
Jun 25, 2015·Microbiology Spectrum·Monika JankuteGurdyal S Besra
Dec 23, 2011·Journal of the American Chemical Society·Claudia TrefzerKai Johnsson
Aug 29, 2017·Journal of Medicinal Chemistry·Maria V BuchieriBrigitte Gicquel
Aug 28, 2021·International Journal of Molecular Sciences·Narimantas ČėnasLidija Kosychova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Respiration

This feed focuses on cellular respiration in bacteria, known as bacterial respiration. Discover the latest research here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.